Non-Hodgkins lymphoma T-cell protocol

ISRCTN	ISRCTN73274643
DOI	https://doi.org/10.1186/ISRCTN73274643
Protocol serial number	NHL9503
Sponsor	Cancer Research UK (CRUK) (UK)
Funders	Cancer Research UK, United Kingdom Children's Cancer Study Group (UKCCSG)

Prospectively registered

Protocol

Statistical analysis plan

Results

Individual participant data

Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Scientific

UKCCCR Register Co-ordinator
MRC Clinical Trials Unit
222 Euston Road
London
NW1 2DA
United Kingdom

Primary study design	Interventional
Study design	Randomised controlled trial
Secondary study design	Randomised controlled trial
Scientific title	Non-Hodgkins lymphoma T-cell protocol
Study objectives	Not provided at time of registration
Ethics approval(s)	Not provided at time of registration
Health condition(s) or problem(s) studied	Lymphoma (non-Hodgkin's)
Intervention	1. Group A: Chemotherapy including third intensification block at 35 weeks 2. Group B: Chemotherapy without third intensification block at 35 weeks
Intervention type	Other
Primary outcome measure(s)	Not provided at time of registration
Key secondary outcome measure(s)	Not provided at time of registration
Completion date	28/02/2000

Participant type(s)	Patient
Age group	Child
Upper age limit	18 Years
Sex	All
Key inclusion criteria	1. T-cell non-Hodgkin's lymphoma 2. Stages I-IV 3. Confirmed remission achieved 4. Less than 25% blasts in bone marrow 5. No circulating blasts in blood 6. Aged <18 years
Key exclusion criteria	Patients with T-cell anaplastic lymphoma or peripheral T-cell lymphoma are excluded.
Date of first enrolment	01/01/1997
Date of final enrolment	28/02/2000

MRC Clinical Trials Unit

London
NW1 2DA
United Kingdom

Individual participant data (IPD) Intention to share	No
IPD sharing plan summary
IPD sharing plan